Evaluation of hybrid ex vivo expanded diabetic peripheral blood endothelial progenitor cell function

Evaluation of hybrid ex vivo expanded diabetic peripheral blood endothelial progenitor cell function - Evaluation of Diabetic EPC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006352

Enrollment

Registered

2011-09-16

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

blood draw

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Non smoking diabetic patients seen at Juntendo University Internal Medicine department

Exclusion criteria

Exclusion criteria: 1)Patient with hemoglobin A1c > 8.0 2)patient with hemodyalisis 3)patient with severe heart disease 4) patient with inflammatory or hematopoietic disease 5)patient with infection 6)patient with malignancy 7)patient who cannot take informed consent

Design outcomes

Primary

Measure	Time frame
Improvement of diabetic endothelial progenitor function	—

Countries

Japan

Contacts

Public ContactRica Tanaka

Juntendo University School of Medicine Department of Plastic Surgery

rtanaka@juntendo.ac.jp03-3813-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026